tiprankstipranks
Trending News
More News >
Gyre Therapeutics (GYRE)
NASDAQ:GYRE

Compare Gyre Therapeutics (GYRE) vs. Competitors

Compare
823 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Gyre Therapeutics
$6.81
$699.86M
201.57
-28.89%
2 Buy
0 Hold
0 Sell
Moderate Buy
KalVista Pharmaceuticals
$14.60
$756.17M
-3.65
76.97%
8 Buy
0 Hold
0 Sell
Strong Buy
Terns Pharmaceuticals
$36.60
$3.93B
-35.47
713.33%
10 Buy
0 Hold
0 Sell
Strong Buy
Day One Biopharmaceuticals
$10.16
$1.11B
-6.84
-18.06%
8 Buy
1 Hold
0 Sell
Strong Buy
Tyra Bioscience
$28.77
$1.55B
-15.31
78.14%
5 Buy
0 Hold
0 Sell
Strong Buy
MBX Biosciences, Inc.
$40.53
$1.84B
-16.93
284.54%
7 Buy
0 Hold
1 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
GYRE
Gyre Therapeutics
7.68
-3.27
-29.86%
KALV
KalVista Pharmaceuticals
14.60
6.30
75.90%
TERN
Terns Pharmaceuticals
36.60
32.17
726.19%
DAWN
Day One Biopharmaceuticals
10.16
-2.38
-18.98%
TYRA
Tyra Bioscience
28.77
12.58
77.70%
MBX
MBX Biosciences, Inc.
40.53
30.64
309.81%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts